In the wake of the highly publicized cardiovascular issues surrounding
the use of nonsteroidal anti-inflammatory drugs (NSAIDs), another
health concern regarding the drugs has crept to the forefront.
According to a Dutch study, NSAIDs double the risk of developing
acute urinary retention -- the abnormal holding of urine within
the bladder, often due to bladder muscle failure. The findings link
the risk to the use of ibuprofen, naproxen (Aleve) and Celebrex,
matching earlier case studies that tied NSAID use to the production
of prostaglandin, a hormone essential to muscle function.
Defining the Extent of Urinary Retention
Risk
Researchers reviewed data on more than 72,000 Dutch men; they then
identified 536 cases of urinary retention and compared their use
of NSAIDs with more than 5,000 men who didn't have the condition.
Data showed:
-
The risk of developing urinary retention doubled among the
men using NSAIDS, compared to those who didn't use the drugs.
-
Patients taking the drugs for the first time or using them
in higher-than-prescribed doses were at the highest risk of
urinary retention.
Forbes.com
July 11, 2005
Archives
of Internal Medicine July 11, 2005;165(13):1547-1551
|